Artelo Biosciences, Inc. (ARTL)
NASDAQ · Manufacturing · Pharmaceutical preparations
ARTL price, last 12 months
Key stats
- Previous close
- $5.17
- Open
- $4.93
- Day range
- $4.43 – $4.93
- 52-week range
- $3.45 – $179.19
- Volume
- 260.2K
- Avg volume (20 days)
- 1.4M
- Market cap
- $2.5M
Performance
Technicals and fundamentals
About Artelo Biosciences, Inc.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.5M